Reuters logo
2 years ago
BRIEF-Array BioPharma, Pierre Fabre announce collaboration for two novel oncology products
November 16, 2015 / 12:45 PM / 2 years ago

BRIEF-Array BioPharma, Pierre Fabre announce collaboration for two novel oncology products

Nov 16 (Reuters) - Array BioPharma Inc :

* Co and Pierre Fabre to globally develop and commercialize Array's late-stage novel oncology products Binimetinib and Encorafenib

* Array to receive a $30 million up-front payment and up to $425 million in additional development and commercialization milestones

* Array retains full commercialization rights to Binimetinib and Encorafenib in United States, Canada, Japan and Korea

* Pierre Fabre to have exclusive rights to commercialize both products in all other countries, including Europe, Asia and Latin America

* Nemo phase 3 trial remains on-track for top-line results by end of 2015

* Array and Pierre fabre have agreed to split future development costs on a 60:40 basis

* All ongoing Binimetinib and Encorafenib clinicaltrials remain substantially funded through completion by Novartis

Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below